Default company panoramic image
Logo

Neurotrack

Diagnosing Alzheimer's disease years before symptoms appear, creating the potential to transform the diagnosis and treatment of Alzheimer's.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Atlanta, GA, USA
  • Currency USD
  • Founded June 2012
  • Employees 1
  • Website neurotrack.com

Company Summary

Neurotrack's technology can diagnose Alzheimer's disease three to four years before symptoms appear, giving pharmaceutical companies and research organizations the tools to recruit truly qualified candidates for clinical trials and more effectively measure drug efficacy, speeding up drug discovery and development. Neurotrack is also on course to become the standard for early clinical screening of Alzheimer's and dementia related disorders.

Team

Advisors

  • Default avatar
    Jeffrey Leavitt, DLA Piper
    Lawyer
    Unconfirmed
    Default avatar
    Kent Elmer, TechCFO
    Accountant
    Unconfirmed